Chuanbin Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chuanbin Guo has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Yuxing Guo
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology
3 shared publications - Qingxiang Li
Peking University School and Hospital of Stomatology
2 shared publications - Yifei Wang
Peking University School and Hospital of Stomatology
2 shared publications C. Mao
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Haidian District, Beijing, PR China
1 shared publicationC.-L. Ni
Department of Oral and Maxillofacial Surgery, Zhangzhou Municipal Hospital of Fujian Province and Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian, PR China
1 shared publicationDian-Can Wang
1 shared publication
Latest Publications
- Open Access
- 8 July 2021
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 12
P2RY14 Is a Potential Biomarker of Tumor Microenvironment Immunomodulation and Favorable Prognosis in Patients With Head and Neck Cancer
The tumor microenvironment (TME) has a crucial role in tumor development, progression, and treatment response. Yet, the exact interaction between cancer biology and the TME is not fully understood. The following study analyzed the correlation between immune/stromal/estimate scores and survival prognosis in head and neck squamous cell carcinoma (HNSC) using a bioinformatic method. As a result, a predictive biomarker, UDP-glucose-specific G(i) protein-coupled P2Y receptor (P2RY14), was discovered. The potential role of P2RY14-driven signaling pathways in the immune-remodeling of TME was then investigated. Briefly, low immune scores were associated with unfavorable prognosis and clinical-stage, larger tumor size, and the down-regulation of P2RY14 in HNSC patients. In addition, the survival analysis showed that HNSC patients with high expression had longer survival than patients with low expression from both TCGA databases and our own patients. We further discovered that P2RY14 is involved in the immune activity in the TME of HNSC; a downregulation of P2RY14 resulted in being an indicator for the conversion of TME status (from immune-dominant to metabolic-dominant status). The intersection analysis of genes co-expressed with P2RY14 indicated that the T-cell receptor signaling pathway and PD-L1 expression and PD-1 checkpoint pathway were candidate signaling pathways driven by the P2RY14 gene in HNSC. Further investigation of immune-associated signaling pathways regulated by P2RY14 may help HNSC patients gain higher immunotherapy benefits.
- 8 July 2021
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 12
Open AccessP2RY14 Is a Potential Biomarker of Tumor Microenvironment Immunomodulation and Favorable Prognosis in Patients With Head and Neck Cancer
The tumor microenvironment (TME) has a crucial role in tumor development, progression, and treatment response. Yet, the exact interaction between cancer biology and the TME is not fully understood. The following study analyzed the correlation between immune/stromal/estimate scores and survival prognosis in head and neck squamous cell carcinoma (HNSC) using a bioinformatic method. As a result, a predictive biomarker, UDP-glucose-specific G(i) protein-coupled P2Y receptor (P2RY14), was discovered. The potential role of P2RY14-driven signaling pathways in the immune-remodeling of TME was then investigated. Briefly, low immune scores were associated with unfavorable prognosis and clinical-stage, larger tumor size, and the down-regulation of P2RY14 in HNSC patients. In addition, the survival analysis showed that HNSC patients with high expression had longer survival than patients with low expression from both TCGA databases and our own patients. We further discovered that P2RY14 is involved in the immune activity in the TME of HNSC; a downregulation of P2RY14 resulted in being an indicator for the conversion of TME status (from immune-dominant to metabolic-dominant status). The intersection analysis of genes co-expressed with P2RY14 indicated that the T-cell receptor signaling pathway and PD-L1 expression and PD-1 checkpoint pathway were candidate signaling pathways driven by the P2RY14 gene in HNSC. Further investigation of immune-associated signaling pathways regulated by P2RY14 may help HNSC patients gain higher immunotherapy benefits.
- 1 July 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (7) , 857-864
High level of CD10 expression is associated with poor overall survival in patients with head and neck cancer
- 1 July 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (7) , 857-864
High level of CD10 expression is associated with poor overall survival in patients with head and neck cancer
- 16 January 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (8) , 1012-1018
Surgical resection of clinically benign tumours in the maxillomandibular deep lobe of the parotid gland via sternocleidomastoid muscle–parotid space approach
- 16 January 2021
- Published by Elsevier in International Journal of Oral and Maxillofacial Surgery
- Vol. 50 (8) , 1012-1018
Surgical resection of clinically benign tumours in the maxillomandibular deep lobe of the parotid gland via sternocleidomastoid muscle–parotid space approach
- 1 January 2020
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 48 (1) , 105-110
MR imaging as a precise technique to evaluate skull-base tumor volume: Comparison of CT, MR imaging and FDG PET from murine and clinical data
- 1 January 2020
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 48 (1) , 105-110
MR imaging as a precise technique to evaluate skull-base tumor volume: Comparison of CT, MR imaging and FDG PET from murine and clinical data
- 1 August 2016
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 122 (2) , e69-e76
Imaging features of medicine-related osteonecrosis of the jaws: comparison between panoramic radiography and computed tomography
- 1 August 2016
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 122 (2) , e69-e76
Imaging features of medicine-related osteonecrosis of the jaws: comparison between panoramic radiography and computed tomography
- 1 July 2016
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 28 (4) , 341-343
Pleomorphic adenoma of the cheek: A case report arising from accessory parotid gland around Stensen's duct orifice
- 1 July 2016
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology
- Vol. 28 (4) , 341-343
Pleomorphic adenoma of the cheek: A case report arising from accessory parotid gland around Stensen's duct orifice